Trupanion (NASDAQ:TRUP) Reaches New 1-Year Low – Time to Sell?

Trupanion, Inc. (NASDAQ:TRUP) hit a new 52-week low during trading on Wednesday . The company traded as low as $23.90 and last traded at $24.10, with a volume of 306457 shares. The stock had previously closed at $24.96.

More Trupanion News

Here are the key news stories impacting Trupanion this week:

• Positive Sentiment: Q1 earnings and revenue beat expectations: TRUP posted $0.11 EPS vs. $0.07 consensus and revenue of $384.05M (vs. ~$379.8M est.), with revenue +12.3% YoY — a clear growth print that supports the rally. Zacks: TRUP Q1 beat
• Positive Sentiment: Secular demand thesis reiterated by management: CEO commentary highlighted widening gap in veterinary costs and pet-owners’ planning needs — a tailwind for insurance adoption and pricing leverage over time. Press release
• Positive Sentiment: Institutional accumulation noted in filings and newsfeeds (Millennium, Goldman, Two Sigma increases), which can provide support to the share price. MarketBeat: institutional flows
• Neutral Sentiment: Company issued Q2 revenue guidance of ~$386M–$392M (consensus ~389.1M) and FY revenue around $1.6B, but EPS guidance was not clearly specified in releases — the revenue ranges are roughly in line with Street estimates, leaving room for interpretation on near-term profitability. (Company guidance entry)
• Neutral Sentiment: Management held an earnings call/transcript is available for detail on margin drivers and cadence; investors will watch commentary on loss ratios, customer acquisition efficiency and vet-direct pay adoption for signals on margin recovery. Earnings call transcript
• Negative Sentiment: Analysts and coverage show rising concern on growth-efficiency tradeoffs and some price-target cuts; media pieces flagged mounting efficiency questions, which could pressure sentiment if management cannot show margin improvement. Investing.com: efficiency concerns
• Negative Sentiment: Profitability remains thin: reported net margin ~1.35% and ROE ~5.4% despite revenue growth — investors focused on whether scale will convert to meaningful margin expansion. MarketBeat: Q1 metrics
• Negative Sentiment: Small insider sale: COO sold 431 shares (minor), which is typically not material but will be noted by some investors. InsiderTrades: COO sale

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on TRUP shares. Piper Sandler decreased their target price on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Bank of America decreased their target price on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Stifel Nicolaus decreased their target price on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a research report on Tuesday, March 31st. Finally, Weiss Ratings cut shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Trupanion has an average rating of “Hold” and a consensus target price of $45.80.

Trupanion Trading Up 1.4%

The business’s 50-day moving average price is $26.31 and its 200 day moving average price is $32.95. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of 54.07 and a beta of 1.66.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.04. The firm had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the company posted ($0.03) earnings per share. On average, equities analysts forecast that Trupanion, Inc. will post 0.5 earnings per share for the current fiscal year.

Insider Activity at Trupanion

In related news, CFO Fawwad Qureshi sold 2,837 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $26.46, for a total value of $75,067.02. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO John R. Gallagher sold 5,283 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $26.52, for a total transaction of $140,105.16. Following the completion of the sale, the chief operating officer directly owned 32,387 shares in the company, valued at $858,903.24. This represents a 14.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 21,503 shares of company stock valued at $578,537 over the last ninety days. Corporate insiders own 5.42% of the company’s stock.

Institutional Trading of Trupanion

A number of institutional investors and hedge funds have recently modified their holdings of TRUP. Royal Bank of Canada raised its holdings in shares of Trupanion by 60.6% during the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after purchasing an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Trupanion by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after purchasing an additional 858 shares during the period. Millennium Management LLC raised its holdings in shares of Trupanion by 73.5% during the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock worth $9,987,000 after purchasing an additional 113,490 shares during the period. Invesco Ltd. raised its holdings in shares of Trupanion by 35.1% during the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock worth $10,392,000 after purchasing an additional 48,781 shares during the period. Finally, Gabelli Funds LLC acquired a new stake in shares of Trupanion during the second quarter worth $249,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.